Careers  |  Sign In  |  Register

Preliminary Success in New Leukemia Drug Trials

Recent data from an Agios leukemia drug trial has shown improved success in treating leukemia, according to an article from Reuters. Forty percent of the 158 patients responded to the treatment and nearly half of those who responded to the treatment saw no more cancer in the bone marrow and normal blood cell counts. A majority of the remaining patients who responded to treatment went into remission with no more cancer in their bone marrow but sustained irregular cell counts. As the clinical trials continue, researchers have high hopes for for the future of the Agios and Celgene drug.


Read the article published by Reuters.